IL88573A - 2-plasmin inhibitor depressant, urokinase secretion accelerator or thrombolytic composition comprising trihydroxypiperidine derivatives, nojirimycin or castanospermine - Google Patents

2-plasmin inhibitor depressant, urokinase secretion accelerator or thrombolytic composition comprising trihydroxypiperidine derivatives, nojirimycin or castanospermine

Info

Publication number
IL88573A
IL88573A IL8857388A IL8857388A IL88573A IL 88573 A IL88573 A IL 88573A IL 8857388 A IL8857388 A IL 8857388A IL 8857388 A IL8857388 A IL 8857388A IL 88573 A IL88573 A IL 88573A
Authority
IL
Israel
Prior art keywords
acid addition
physiologically acceptable
acceptable acid
addition salt
nojirimycin
Prior art date
Application number
IL8857388A
Other languages
English (en)
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of IL88573A publication Critical patent/IL88573A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
IL8857388A 1987-12-09 1988-12-04 2-plasmin inhibitor depressant, urokinase secretion accelerator or thrombolytic composition comprising trihydroxypiperidine derivatives, nojirimycin or castanospermine IL88573A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31134887 1987-12-09

Publications (1)

Publication Number Publication Date
IL88573A true IL88573A (en) 1994-05-30

Family

ID=18016066

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8857388A IL88573A (en) 1987-12-09 1988-12-04 2-plasmin inhibitor depressant, urokinase secretion accelerator or thrombolytic composition comprising trihydroxypiperidine derivatives, nojirimycin or castanospermine

Country Status (11)

Country Link
EP (1) EP0319986B1 (de)
KR (1) KR960009417B1 (de)
AT (1) ATE149836T1 (de)
BE (1) BE1004874A4 (de)
CA (1) CA1316831C (de)
CH (1) CH677610A5 (de)
DE (1) DE3855824T2 (de)
FR (1) FR2626470B1 (de)
GB (2) GB8827701D0 (de)
IL (1) IL88573A (de)
SE (1) SE502110C2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0430983B1 (de) * 1988-08-10 1994-04-20 The Australian National University Verwendung von castanospermin als ein antientzündliches und immununterdrückendes mittel
AU3978697A (en) * 1996-08-14 1998-03-06 Myung Hee Chun Plasmin-depletion therapy
EP1903034A1 (de) * 2006-09-19 2008-03-26 Technische Universität Graz Iminozucker-Glykokonjugate

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54106477A (en) * 1978-02-03 1979-08-21 Nippon Shinyaku Co Ltd Moranoline derivative
JPS5943946B2 (ja) * 1978-04-28 1984-10-25 日本新薬株式会社 Ｎ−アルケニルモラノリン誘導体
GB2020278B (en) * 1978-05-03 1983-02-23 Nippon Shinyaku Co Ltd Moranoline dervitives
JPS5943949B2 (ja) * 1978-09-29 1984-10-25 日本新薬株式会社 モラノリンのｎ−置換誘導体
JPS6026387B2 (ja) * 1979-01-20 1985-06-24 日本新薬株式会社 シンナミルモラノリン誘導体
JPS5943947B2 (ja) * 1978-05-03 1984-10-25 日本新薬株式会社 Ｎ−置換モラノリン誘導体
DE2925943A1 (de) * 1979-06-27 1981-01-29 Bayer Ag 1-alkadien-2,4-yl-2-hydroxymethyl3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPS56108767A (en) * 1980-01-28 1981-08-28 Nippon Shinyaku Co Ltd Bismoranoline derivative
DE3007078A1 (de) * 1980-02-26 1981-09-10 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
JPS60224675A (ja) * 1984-04-24 1985-11-09 Meiji Seika Kaisha Ltd 新規１−デオキシノジリマイシン誘導体およびそれを含有する血中脂質低下剤
CA1327970C (en) * 1985-05-24 1994-03-22 Paul S. Liu Isolation of castanospermine and its use as an antidiabetic agent
ATE126696T1 (de) * 1985-12-23 1995-09-15 Hutchinson Fred Cancer Res Regulierung der retroviralen replikation, infektion und pathogenese.
ZA883925B (en) * 1987-06-08 1989-02-22 Merrell Dow Pharma Inhibitors of glycoprotein processing having anti-retroviral activity

Also Published As

Publication number Publication date
CA1316831C (en) 1993-04-27
FR2626470B1 (fr) 1994-12-09
KR960009417B1 (ko) 1996-07-19
CH677610A5 (de) 1991-06-14
BE1004874A4 (fr) 1993-02-16
ATE149836T1 (de) 1997-03-15
FR2626470A1 (fr) 1989-08-04
DE3855824T2 (de) 1997-10-16
SE8804436D0 (sv) 1988-12-08
EP0319986B1 (de) 1997-03-12
GB8827927D0 (en) 1989-01-05
EP0319986A2 (de) 1989-06-14
SE8804436L (sv) 1989-06-10
DE3855824D1 (de) 1997-04-17
EP0319986A3 (de) 1992-09-30
KR890009399A (ko) 1989-08-01
SE502110C2 (sv) 1995-08-21
GB2213374B (en) 1992-01-29
GB2213374A (en) 1989-08-16
GB8827701D0 (en) 1988-12-29

Similar Documents

Publication Publication Date Title
CA2113229A1 (en) Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
HU9500240D0 (en) New prolin-amide derivatives and pharmaceutical compositions containing them as active component
AU6690686A (en) Piperdine derivative and pharmaceutical composition
ES2048109A1 (es) Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
HUT52770A (en) Process for producing new 2-amino-pyrimidinone derivatives and pharmaceutical compositions containing them
HK1003708A1 (en) Peripheral vasodilating agent containing n-acylated 4-amino piperidine derivatives as active ingredients
HU895609D0 (en) Process for the preparation of novel 1,4-diazepine derivatives and pharmaceutical compositions containing such compounds
HUT52059A (en) Process for producing pharmaceutical compositions and new quinoline derivatives as a group of active components
AU1433588A (en) 1-phenyl-3-naphthalenyloxypropanamines
ES8802420A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
EP0194599A3 (de) Benzamidderivate, Verfahren zu ihrer Herstellung und diese enthaltende Boden-Fungizide
ES557061A0 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina
IL88573A (en) 2-plasmin inhibitor depressant, urokinase secretion accelerator or thrombolytic composition comprising trihydroxypiperidine derivatives, nojirimycin or castanospermine
EP0123962A3 (en) Novel benzimidazole derivative, process for the preparation thereof and pharmaceutical composition
CA1264753C (en) 2-PYRIDYLCARBOXAMIDES
CA2118425A1 (en) Benzothiazolesulfonamide derivative, Method for Preparing the Same, and Use Thereof
ES8801615A1 (es) Un procedimiento para preparar esteres de acidos ciclopropanocarboxolico que contienen fluor.
ATE50248T1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
GR3007219T3 (de)
AU655869B2 (en) An amphoteric tricyclic compound
AU639875B2 (en) 5-amino-5,6,7,8-tetrahydroquinolines and related compounds and pharmaceutical use
EP0414903A4 (en) New thioproline derivative
EP0376162A3 (de) Mittel zur Verhinderung von Zahnbelagbildung
WO2001035938A3 (de) Pharmakologisch aktive tetrahydrothiopyran-4-ol-derivate, verfahren zu ihrer herstellung und verwendung
ATE131480T1 (de) Pyrimidoindolderivate und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
RH Patent void